PT  - JOURNAL ARTICLE
AU  - Hu, Z.
AU  - Jiang, D.
AU  - Zhao, X.
AU  - Yang, J.
AU  - Liang, D.
AU  - Wang, H.
AU  - Zhao, C.
AU  - Liao, J.
TI  - Predicting Drug Treatment Outcomes in Childrens with Tuberous Sclerosis Complex–Related Epilepsy: A Clinical Radiomics Study
AID  - 10.3174/ajnr.A7911
DP  - 2023 Jun 22
TA  - American Journal of Neuroradiology
4099  - http://www.ajnr.org/content/early/2023/06/22/ajnr.A7911.short
4100  - http://www.ajnr.org/content/early/2023/06/22/ajnr.A7911.full
AB  - BACKGROUND AND PURPOSE: Highly predictive markers of drug treatment outcomes of tuberous sclerosis complex–related epilepsy are a key unmet clinical need. The objective of this study was to identify meaningful clinical and radiomic predictors of outcomes of epilepsy drug treatment in patients with tuberous sclerosis complex.MATERIALS AND METHODS: A total of 105 children with tuberous sclerosis complex–related epilepsy were enrolled in this retrospective study. The pretreatment baseline predictors that were used to predict drug treatment outcomes included patient demographic and clinical information, gene data, electroencephalogram data, and radiomic features that were extracted from pretreatment MR imaging scans. The Spearman correlation coefficient and least absolute shrinkage and selection operator were calculated to select the most relevant features for the drug treatment outcome to build a comprehensive model with radiomic and clinical features for clinical application.RESULTS: Four MR imaging–based radiomic features and 5 key clinical features were selected to predict the drug treatment outcome. Good discriminative performances were achieved in testing cohorts (area under the curve = 0.85, accuracy = 80.0%, sensitivity = 0.75, and specificity = 0.83) for the epilepsy drug treatment outcome. The model of radiomic and clinical features resulted in favorable calibration curves in all cohorts.CONCLUSIONS: Our results suggested that the radiomic and clinical features model may predict the epilepsy drug treatment outcome. Age of onset, infantile spasms, antiseizure medication numbers, epileptiform discharge in left parieto-occipital area of electroencephalography, and gene mutation type are the key clinical factors to predict the epilepsy drug treatment outcome. The texture and first-order statistic features are the most valuable radiomic features for predicting drug treatment outcomes.ASMantiseizure medicationAUCarea under the receiver operating curveEEGelectroencephalographyGLCMgray-level co-occurrence matrixGLDMgray-level dependence matrixGLRLMgray-level run-length matrixGLSZMgray-level size zone matrixLASSOleast absolute shrinkage and selection operatorTSCtuberous sclerosis complex